AC
Applied Clinical Trials
ACT Brief: Zip Code Trial Access, Smaller Biotech APAC Perceptions, and Pimjetmi Tumor Approval
0:00-1:30
In today’s ACT Brief, we examine how ZIP code shapes trial availability and enrollment, why smaller biotechs hold outdated views of APAC sites, and how FDA approved Pimjetmi for symptomatic tenosynovial giant cell tumor.
Publisher
Applied Clinical Trials
Link
audioboom.com/posts/8976517
Published
November 13, 2026
Duration
2 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
AC
Applied Clinical Trials
@appliedclinicaltrials
#zipcodetrial #smallerbiotechapac #pimjetmitumorapproval #lifesciences
